Graft Dysfunction clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

    Sorry, not yet accepting patients

    Lung transplant recipient survival lags other solid organ recipients, with the main early cause of death being primary graft dysfunction (PGD). PGD occurs in up to 1/3 of all recipients, is driven by the body's innate immune response, and has no…

    at UCSF

Our lead scientists for Graft Dysfunction research studies include .

Last updated: